PT Medikaloka Hermina Tbk (ISX:HEAL) Long-Term Debt: Rp3,022,704 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:HEAL PT Medikaloka Hermina Tbk ISX:HEAL
67 GF Score
Price Rp700.00
GF Value Rp1,561.19
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is PT Medikaloka Hermina Tbk Long-Term Debt?

PT Medikaloka Hermina Tbk ISX:HEAL -1.41% 67 Long-Term Debt is Rp3,022,704 Mil as of Jun. 2026. GuruFocus rates ISX:HEAL with a GF Score™ of 67/100 and a GF Value™ of Rp1,561.19 (Significantly Undervalued). The stock has 5 warning signs investors should review.

PT Medikaloka Hermina Tbk's Long-Term Debt for the quarter that ended in Jun. 2026 was Rp3,022,704 Mil.

PT Medikaloka Hermina Tbk's quarterly Long-Term Debt increased from Dec. 2025 (Rp2,638,881 Mil) to Mar. 2026 (Rp2,903,459 Mil) and increased from Mar. 2026 (Rp2,903,459 Mil) to Jun. 2026 (Rp3,022,704 Mil).

PT Medikaloka Hermina Tbk's annual Long-Term Debt increased from Dec. 2023 (Rp2,000,842 Mil) to Dec. 2024 (Rp2,819,744 Mil) but then declined from Dec. 2024 (Rp2,819,744 Mil) to Dec. 2025 (Rp2,638,881 Mil).

PT Medikaloka Hermina Tbk  (ISX:HEAL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

PT Medikaloka Hermina Tbk Long-Term Debt Related Terms

PT Medikaloka Hermina Tbk Long-Term Debt Historical Data

* Premium members only.

The historical data trend for PT Medikaloka Hermina Tbk's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Medikaloka Hermina Tbk Long-Term Debt Chart

PT Medikaloka Hermina Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,473,641.00 1,160,854.00 2,000,842.00 2,819,744.00 2,638,881.00

PT Medikaloka Hermina Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,190,116.00 3,067,204.00 2,638,881.00 2,903,459.00 3,022,704.00
ISX:HEAL
67GF Score
PT Medikaloka Hermina Tbk ISX:HEAL
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of Rp3,022,704 Mil mean?
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Long-Term Debt of Rp3,022,704 Mil as of Jun. 2026.
Is PT Medikaloka Hermina Tbk's Long-Term Debt too high?
PT Medikaloka Hermina Tbk's current Long-Term Debt is Rp3,022,704 Mil. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Long-Term Debt compare to HCA and THC?
PT Medikaloka Hermina Tbk's Long-Term Debt of Rp3,022,704 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. PT Medikaloka Hermina Tbk's current Long-Term Debt is Rp3,022,704 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,561.19, compared to a current price of Rp700.00 — trading 55.2% below its estimated fair value. The current Long-Term Debt is Rp3,022,704 Mil. PT Medikaloka Hermina Tbk's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Long-Term Debt is Rp3,022,704 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?

Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued. The current stock price of Rp700.00 is trading 55.2% below its estimated GF Value™ of Rp1,561.19. GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.

Key valuation signals for ISX:HEAL:

  • Long-Term Debt: Rp3,022,704 Mil
  • GF Value™: Rp1,561.19 vs. price of Rp700.00 (55.2% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Medikaloka Hermina Tbk Business Description

Address Jalan Selangit B-10 Kavling No. 4, Hermina Tower, Kemayoran, Jakarta, IDN, 10610
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
67GF Score

Get the complete analysis for ISX:HEAL

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp700.00
Price
Rp1,561.19
GF Value